2,519 research outputs found

    Inflammation as a Central Mechanism in Alzheimer\u27s Disease

    Get PDF
    Alzheimer\u27s disease (AD) is a progressive neurodegenerative disorder that is characterized by cognitive decline and the presence of two core pathologies, amyloid β plaques and neurofibrillary tangles. Over the last decade, the presence of a sustained immune response in the brain has emerged as a third core pathology in AD. The sustained activation of the brain\u27s resident macrophages (microglia) and other immune cells has been demonstrated to exacerbate both amyloid and tau pathology and may serve as a link in the pathogenesis of the disorder. In the following review, we provide an overview of inflammation in AD and a detailed coverage of a number of microglia-related signaling mechanisms that have been implicated in AD. Additional information on microglia signaling and a number of cytokines in AD are also reviewed. We also review the potential connection of risk factors for AD and how they may be related to inflammatory mechanisms

    Differences between neurosurgeons and orthopaedic surgeons in classifying cervical dislocation injuries and making assessment and treatment decisions: a multicenter reliability study

    Get PDF
    Journal ArticleVariability exists in the management of cervical spinal injuries. The goal of this study was to assess the effect of training specialty (orthopedic surgery vs neurosurgery) on management of cervical dislocations

    Mid-frequency aperture arrays: the future of radio astronomy

    Full text link
    Aperture array (AA) technology is at the forefront of new developments and discoveries in radio astronomy. Currently LOFAR is successfully demonstrating the capabilities of dense and sparse AA's at low frequencies. For the mid-frequencies, from 450 to 1450MHz, AA's still have to prove their scientific value with respect to the existing dish technology. Their large field-of-view and high flexibility puts them in an excellent position to do so. The Aperture Array Verification Program is dedicated to demonstrate the feasibility of AA's for science in general and SKA in particular. For the mid-frequency range this has lead to the development of EMBRACE, which has already demonstrated the enormous flexibility of AA systems by observing HI and a pulsar simultaneously. It also serves as a testbed to demonstrate the technological reliability and stability of AA's. The next step will put AA technology at a level where it can be used for cutting-edge science. In this paper we discuss the developments to move AA technology from an engineering activity to a fully science capable instrument. We present current results from EMBRACE, ongoing tests of the system, and plans for EMMA, the next step in mid-frequency AA technology.Comment: 8 pages, 7 figures, proceedings of Resolving The Sky - Radio Astronomy: Past, Present and Future (RTS2012), April 17-20, 2012, Manchester, U

    Books Reviewed

    Get PDF

    A Panel of Cytochrome P450 BM3 Variants to Produce Drug Metabolites and Diversify Lead Compounds

    Get PDF
    Herein we demonstrate that a small panel of variants of cytochrome P450 BM3 from Bacillus megaterium covers the breadth of reactivity of human P450s by producing 12 of 13 mammalian metabolites for two marketed drugs, verapamil and astemizole, and one research compound. The most active enzymes support preparation of individual metabolites for preclinical bioactivity and toxicology evaluations. Underscoring their potential utility in drug lead diversification, engineered P450 BM3 variants also produce novel metabolites by catalyzing reactions at carbon centers beyond those targeted by animal and human P450s. Production of a specific metabolite can be improved by directed evolution of the enzyme catalyst. Some variants are more active on the more hydrophobic parent drug than on its metabolites, which limits production of multiply-hydroxylated species, a preference that appears to depend on the evolutionary history of the P450 variant
    corecore